Patterns of Recurrence After Resection of Pancreatic Ductal AdenocarcinomaRobert Jones, Richard Jackson, Paula Ghaneh et al.|JAMA Surgery|2019Cited by 282
HENT1 tumor levels to predict survival of pancreatic ductal adenocarcinoma patients who received adjuvant gemcitabine and adjuvant 5FU on the ESPAC trials.John P. Neoptolemos, William Greenhalf, Paula Ghaneh et al.|Journal of Clinical Oncology|2013Cited by 17